These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Evidence supporting a role for corticotropin-releasing factor type 2 (CRF2) receptors in the regulation of subpopulations of serotonergic neurons. Staub DR; Evans AK; Lowry CA Brain Res; 2006 Jan; 1070(1):77-89. PubMed ID: 16403469 [TBL] [Abstract][Full Text] [Related]
5. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval. Fekete EM; Inoue K; Zhao Y; Rivier JE; Vale WW; Szücs A; Koob GF; Zorrilla EP Neuropsychopharmacology; 2007 May; 32(5):1052-68. PubMed ID: 17019404 [TBL] [Abstract][Full Text] [Related]
6. Ingestive responses to administration of stress hormones in baboons. Shade RE; Blair-West JR; Carey KD; Madden LJ; Weisinger RS; Rivier JE; Vale WW; Denton DA Am J Physiol Regul Integr Comp Physiol; 2002 Jan; 282(1):R10-8. PubMed ID: 11742818 [TBL] [Abstract][Full Text] [Related]
7. Comparison of central administration of corticotropin-releasing hormone and urocortin on food intake, conditioned taste aversion, and c-Fos expression. Benoit SC; Thiele TE; Heinrichs SC; Rushing PA; Blake KA; Steeley RJ Peptides; 2000 Mar; 21(3):345-51. PubMed ID: 10793215 [TBL] [Abstract][Full Text] [Related]
8. Central structures necessary and sufficient for ingestive and glycemic responses to Urocortin I administration. Daniels D; Markison S; Grill HJ; Kaplan JM J Neurosci; 2004 Dec; 24(50):11457-62. PubMed ID: 15601952 [TBL] [Abstract][Full Text] [Related]
9. Urocortin in the ventromedial hypothalamic nucleus acts as an inhibitor of feeding behavior in rats. Ohata H; Suzuki K; Oki Y; Shibasaki T Brain Res; 2000 Apr; 861(1):1-7. PubMed ID: 10751559 [TBL] [Abstract][Full Text] [Related]
10. Injections of urocortin 1 into the basolateral amygdala induce anxiety-like behavior and c-Fos expression in brainstem serotonergic neurons. Spiga F; Lightman SL; Shekhar A; Lowry CA Neuroscience; 2006; 138(4):1265-76. PubMed ID: 16488545 [TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal corticotropin-releasing factor and urocortin induce Fos expression in brain and spinal autonomic nuclei and long lasting stimulation of colonic motility in rats. Maillot C; Wang L; Million M; Taché Y Brain Res; 2003 Jun; 974(1-2):70-81. PubMed ID: 12742625 [TBL] [Abstract][Full Text] [Related]
12. Central action of basic fibroblast growth factor on ingestive behaviour in mice. Denton DA; Blair-West JR; McBurnie M; Weisinger RS; Logan A; Gonzales AM; Baird A Physiol Behav; 1995 Apr; 57(4):747-52. PubMed ID: 7777612 [TBL] [Abstract][Full Text] [Related]
13. Hypothalamic paraventricular nucleus injections of urocortin alter food intake and respiratory quotient. Currie PJ; Coscina DV; Bishop C; Coiro CD; Koob GF; Rivier J; Vale W Brain Res; 2001 Oct; 916(1-2):222-8. PubMed ID: 11597609 [TBL] [Abstract][Full Text] [Related]
14. The association of thirst, sodium appetite and vasopressin release with c-fos expression in the forebrain of the rat after intracerebroventricular injection of angiotensin II, angiotensin-(1-7) or carbachol. Mahon JM; Allen M; Herbert J; Fitzsimons JT Neuroscience; 1995 Nov; 69(1):199-208. PubMed ID: 8637618 [TBL] [Abstract][Full Text] [Related]
15. Comparison of brain urocortin-3 and corticotrophin-releasing factor for physiological responses in chicks. Ogino M; Okumura A; Khan MS; Cline MA; Tachibana T Physiol Behav; 2014 Feb; 125():57-61. PubMed ID: 24291384 [TBL] [Abstract][Full Text] [Related]
16. Astressin, a corticotropin releasing factor antagonist, reverses the anxiogenic effects of urocortin when administered into the basolateral amygdala. Sajdyk TJ; Gehlert DR Brain Res; 2000 Sep; 877(2):226-34. PubMed ID: 10986336 [TBL] [Abstract][Full Text] [Related]
17. Central administration of urocortin inhibits vasopressin release in conscious rats. Kakiya S; Yokoi H; Arima H; Iwasaki Y; Oki Y; Oiso Y Neurosci Lett; 1998 May; 248(2):144-6. PubMed ID: 9654364 [TBL] [Abstract][Full Text] [Related]
18. Urocortin, corticotropin releasing factor-2 receptors and energy balance. Cullen MJ; Ling N; Foster AC; Pelleymounter MA Endocrinology; 2001 Mar; 142(3):992-9. PubMed ID: 11181511 [TBL] [Abstract][Full Text] [Related]
19. Central urocortin activation of sympathetic-regulated energy metabolism in Wistar rats. De Fanti BA; Martínez JA Brain Res; 2002 Mar; 930(1-2):37-41. PubMed ID: 11879793 [TBL] [Abstract][Full Text] [Related]
20. Expression of c-fos in restricted areas of the basal forebrain and brainstem following single or combined intraventricular infusions of vasopressin and corticotropin-releasing factor. Andreae LC; Herbert J Neuroscience; 1993 Apr; 53(3):735-48. PubMed ID: 8487952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]